Stock Price Quote

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2368.959.6 (+0.41 %)
PREV CLOSE ( ) 2359.35
OPEN PRICE ( ) 2359.40
BID PRICE (QTY) 2369.00 (17)
OFFER PRICE (QTY) 2370.00 (14)
VOLUME 217
TODAY'S LOW / HIGH ( )2344.10 2383.05
52 WK LOW / HIGH ( )1626 2822.5
NSE2371.309.9 (+0.42 %)
PREV CLOSE( ) 2361.40
OPEN PRICE ( ) 2396.80
BID PRICE (QTY) 2371.05 (1)
OFFER PRICE (QTY) 2373.05 (1)
VOLUME 1181
TODAY'S LOW / HIGH( ) 2330.05 2396.80
52 WK LOW / HIGH ( )1630 2823.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981
Management Info
- Chairman Rahul J Nachane - Managing Director
Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE

NEWS

18Jun Ngl Fine-Chem informs about disclosure
Ngl Fine-Chem has informed that the Company has received Certificate of..
01Jun NGL Fine-Chem submits analyst meet out
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure..
28May NGL Fine-Chem informs about revised in
Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure..
02May NGL Fine-Chem informs about issuance o
In compliance with the provisions of Regulation 39(3) of SEBI (Listing O..
19Mar NGL Fine-Chem submits postal ballot no
With reference to its earlier announcement dated March 18, 2024, wherein..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit108.5385.19
Gross Profit 142.38 507.08
Operating Profit 167.6601.94
Net Sales 956.093289.73

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  6732.30 (2.60%)
M.Cap ( in Cr)8563.76
Glaxosmithkline Phar (BSE)
peergroup  2671.80 (5.24%)
M.Cap ( in Cr)45316.11
Astrazeneca Pharma I (BSE)
peergroup  6482.05 (2.06%)
M.Cap ( in Cr)16117.25
Mercury Laboratories (BSE)
peergroup  933.00 (5.78%)
M.Cap ( in Cr)111.96
Torrent Pharma (BSE)
peergroup  2877.00 (1.64%)
M.Cap ( in Cr)95969.59

Shareholding Pattern

PROMOTERS 72.74%
NON-INSTITUTION 27.16%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About NGL Fine-Chem Ltd.

NGL Fine-Chem Ltd. was incorporated in the year 1981. Its today's share price is 2368.95. Its current market capitalisation stands at Rs 1472.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2750.53 Cr and Total Income of Rs.2826.65 Cr. The company's management includes Dhananjay Mungale, Pallavi Pednekar, Rajesh N Lawande, Rahul J Nachane, Sarala Menon, Jayaram Sitaram, Ajita Nachane.

It is listed on the BSE with a BSE Code of 524774 , NSE with an NSE Symbol of NGLFINE and ISIN of INE887E01022. It's Registered office is at 301 E Square,Subhash Road,Vile Parle (East)Mumbai-400057, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bharat Gandhi & Co, Manek & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.